Lv6
3170 积分 2023-03-06 加入
The evolving landscape of targets for lipid lowering: from molecular mechanisms to translational implications
29天前
已完结
Fixed-dose combination of rosuvastatin and ezetimibe: treating hypercholesteremia according to cardiovascular risk
1个月前
已完结
Efficacy and Safety of Single-Pill Combination of Rosuvastatin and Ezetimibe in Chinese Patients with Primary Hypercholesterolemia Inadequately Controlled by Statin Treatment (ROZEL): A Randomized, Double-Blind, Double Dummy, Active-Controlled Phase 3 Clinical Trial
3个月前
已完结
Combination Therapy of Rosuvastatin and Ezetimibe in Patients with High Cardiovascular Risk
3个月前
已完结
Fixed-dose combination of rosuvastatin and ezetimibe: treating hypercholesteremia according to cardiovascular risk
3个月前
已完结
A Phase 3 Randomized Controlled Trial to Evaluate Efficacy and Safety of New-Formulation Zenon (Rosuvastatin/Ezetimibe Fixed-Dose Combination) in Primary Hypercholesterolemia Inadequately Controlled by Statins
3个月前
已完结
Safety and efficacy of moderate‐intensity statin with ezetimibe in elderly patients with atherosclerotic cardiovascular disease
3个月前
已完结
Fixed-dose combination of rosuvastatin and ezetimibe: treating hypercholesteremia according to cardiovascular risk
3个月前
已完结
Moderate-Intensity Statin With Ezetimibe Combination Therapy vs High-Intensity Statin Monotherapy in Patients at Very High Risk of Atherosclerotic Cardiovascular Disease
3个月前
已完结
Indirect comparison of statin–ezetimibe and statin–PCSK9 inhibitor combination therapies for coronary artery plaque regression in acute coronary syndrome
3个月前
已完结
皖公网安备34019202002308
